43 results on '"Hémon B"'
Search Results
2. Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease: Demonstration with a panel of antibodies against Tau proteins
- Author
-
Delacourte, A., Flament, S., Dibe, E. M., Hublau, P., Sablnnière, P., Hémon, B., Shérrer, V., and Défossez, A.
- Published
- 1990
- Full Text
- View/download PDF
3. Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort
- Author
-
Matejcic, M., primary, Lesueur, F., additional, Biessy, C., additional, Renault, A.L., additional, Mebirouk, N., additional, Yammine, S., additional, Keski‐Rahkonen, P., additional, Li, K., additional, Hémon, B., additional, Weiderpass, E., additional, Rebours, V., additional, Boutron‐Ruault, M.C., additional, Carbonnel, F., additional, Kaaks, R., additional, Katzke, V., additional, Kuhn, T., additional, Boeing, H., additional, Trichopoulou, A., additional, Palli, D., additional, Agnoli, C., additional, Panico, S., additional, Tumino, R., additional, Sacerdote, C., additional, Quirós, J.R., additional, Duell, E.J., additional, Porta, M., additional, Sánchez, M.J., additional, Chirlaque, M.D., additional, Barricarte, A., additional, Amiano, P., additional, Ye, W., additional, Peeters, P.H., additional, Khaw, K.T., additional, Perez‐Cornago, A., additional, Key, T.J., additional, Bueno‐de‐Mesquita, H.B., additional, Riboli, E., additional, Vineis, P., additional, Romieu, I., additional, Gunter, M.J., additional, and Chajès, V., additional
- Published
- 2018
- Full Text
- View/download PDF
4. Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort
- Author
-
Matejcic, M., Lesueur, F., Biessy, C., Renault, A. L., Mebirouk, N., Yammine, S., Keski-Rahkonen, P., Li, K., Hémon, B., Weiderpass, E., Rebours, V., Boutron-Ruault, M. C., Carbonnel, F., Kaaks, R., Katzke, V., Kuhn, T., Boeing, H., Trichopoulou, A., Palli, D., Agnoli, C., Panico, S., Tumino, R., Sacerdote, C., Quirós, J. R., Duell, E. J., Porta, M., Sánchez, M. J., Chirlaque, M. D., Barricarte, A., Amiano, P., Ye, W., Peeters, P. H., Khaw, K. T., Perez-Cornago, A., Key, T. J., Bueno-de-Mesquita, H. B., Riboli, E., Vineis, P., Romieu, I., Gunter, M. J., Chajès, V., Matejcic, M., Lesueur, F., Biessy, C., Renault, A. L., Mebirouk, N., Yammine, S., Keski-Rahkonen, P., Li, K., Hémon, B., Weiderpass, E., Rebours, V., Boutron-Ruault, M. C., Carbonnel, F., Kaaks, R., Katzke, V., Kuhn, T., Boeing, H., Trichopoulou, A., Palli, D., Agnoli, C., Panico, S., Tumino, R., Sacerdote, C., Quirós, J. R., Duell, E. J., Porta, M., Sánchez, M. J., Chirlaque, M. D., Barricarte, A., Amiano, P., Ye, W., Peeters, P. H., Khaw, K. T., Perez-Cornago, A., Key, T. J., Bueno-de-Mesquita, H. B., Riboli, E., Vineis, P., Romieu, I., Gunter, M. J., and Chajès, V.
- Published
- 2018
5. Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort
- Author
-
JC onderzoeksprogramma Kanker, Cancer, Epi Kanker Team B, UMC Utrecht, Matejcic, M., Lesueur, F., Biessy, C., Renault, A. L., Mebirouk, N., Yammine, S., Keski-Rahkonen, P., Li, K., Hémon, B., Weiderpass, E., Rebours, V., Boutron-Ruault, M. C., Carbonnel, F., Kaaks, R., Katzke, V., Kuhn, T., Boeing, H., Trichopoulou, A., Palli, D., Agnoli, C., Panico, S., Tumino, R., Sacerdote, C., Quirós, J. R., Duell, E. J., Porta, M., Sánchez, M. J., Chirlaque, M. D., Barricarte, A., Amiano, P., Ye, W., Peeters, P. H., Khaw, K. T., Perez-Cornago, A., Key, T. J., Bueno-de-Mesquita, H. B., Riboli, E., Vineis, P., Romieu, I., Gunter, M. J., Chajès, V., JC onderzoeksprogramma Kanker, Cancer, Epi Kanker Team B, UMC Utrecht, Matejcic, M., Lesueur, F., Biessy, C., Renault, A. L., Mebirouk, N., Yammine, S., Keski-Rahkonen, P., Li, K., Hémon, B., Weiderpass, E., Rebours, V., Boutron-Ruault, M. C., Carbonnel, F., Kaaks, R., Katzke, V., Kuhn, T., Boeing, H., Trichopoulou, A., Palli, D., Agnoli, C., Panico, S., Tumino, R., Sacerdote, C., Quirós, J. R., Duell, E. J., Porta, M., Sánchez, M. J., Chirlaque, M. D., Barricarte, A., Amiano, P., Ye, W., Peeters, P. H., Khaw, K. T., Perez-Cornago, A., Key, T. J., Bueno-de-Mesquita, H. B., Riboli, E., Vineis, P., Romieu, I., Gunter, M. J., and Chajès, V.
- Published
- 2018
6. Tau 64 and Tau 69: Two Early Biochemical Markers of Neurofibrillary Degeneration
- Author
-
Delacourte, A., Flament, S., Défossez, A., Buee, L., Hémon, B., Parent, M., Furby, A., Leys, D., Goudemand, M., Destee, A., Petit, H., Christen, Yves, editor, Boller, François, editor, Katzman, Robert, editor, Rascol, André, editor, and Signoret, Jean-Louis, editor
- Published
- 1989
- Full Text
- View/download PDF
7. Double rôle de MUC1 dans l’ischémie-reperfusion rénale
- Author
-
Gibier, J.B., primary, Swierczewski, T., additional, Fanchon, M., additional, Hémon, B., additional, Gaudelot, K., additional, Van Seuningen, I., additional, Aubert, S., additional, Perrais, M., additional, and Gnemmi, V., additional
- Published
- 2017
- Full Text
- View/download PDF
8. Sources of pre-analytical variations in yield of DNA extracted from blood samples: Analysis of 50,000 DNA samples in EPIC
- Author
-
Caboux, E. Lallemand, C. Ferro, G. Hémon, B. Mendy, M. Biessy, C. Sims, M. Wareham, N. Britten, A. Boland, A. Hutchinson, A. Siddiq, A. Vineis, P. Riboli, E. Romieu, I. Rinaldi, S. Gunter, M.J. Peeters, P.H.M. van der Schouw, Y.T. Travis, R. Bueno-de-Mesquita, H.B. Canzian, F. Sánchez, M.-J. Skeie, G. Olsen, K.S. Lund, E. Bilbao, R. Sala, N. Barricarte, A. Palli, D. Navarro, C. Panico, S. Redondo, M.L. Polidoro, S. Dossus, L. Boutron-Ruault, M.C. Clavel-Chapelon, F. Trichopoulou, A. Trichopoulos, D. Lagiou, P. Boeing, H. Fisher, E. Tumino, R. Agnoli, C. Hainaut, P.
- Abstract
The European Prospective Investigation into Cancer and nutrition (EPIC) is a long-term, multi-centric prospective study in Europe investigating the relationships between cancer and nutrition. This study has served as a basis for a number of Genome-Wide Association Studies (GWAS) and other types of genetic analyses. Over a period of 5 years, 52,256 EPIC DNA samples have been extracted using an automated DNA extraction platform. Here we have evaluated the pre-analytical factors affecting DNA yield, including anthropometric, epidemiological and technical factors such as center of subject recruitment, age, gender, body-mass index, disease case or control status, tobacco consumption, number of aliquots of buffy coat used for DNA extraction, extraction machine or procedure, DNA quantification method, degree of haemolysis and variations in the timing of sample processing. We show that the largest significant variations in DNA yield were observed with degree of haemolysis and with center of subject recruitment. Age, gender, body-mass index, cancer case or control status and tobacco consumption also significantly impacted DNA yield. Feedback from laboratories which have analyzed DNA with different SNP genotyping technologies demonstrate that the vast majority of samples (approximately 88%) performed adequately in different types of assays. To our knowledge this study is the largest to date to evaluate the sources of pre-analytical variations in DNA extracted from peripheral leucocytes. The results provide a strong evidence-based rationale for standardized recommendations on blood collection and processing protocols for large-scale genetic studies. © 2012 Caboux et al.
- Published
- 2012
9. European Prospective Investigation into Cancer and Nutrition (EPIC): Study populations and data collection
- Author
-
Riboli, E. Hunt, K.J. Slimani, N. Ferrari, P. Norat, T. Fahey, M. Charrondière, U.R. Hémon, B. Casagrande, C. Vignat, J. Overvad, K. Tjønneland, A. Clavel-Chapelon, F. Thiébaut, A. Wahrendorf, J. Boeing, H. Trichopoulos, D. Trichopoulou, A. Vineis, P. Palli, D. Bueno-de-Mesquita, H.B. Peeters, P.H.M. Lund, E. Engeset, D. González, C.A. Barricarte, A. Berglund, G. Hallmans, G. Day, N.E. Key, T.J. Kaaks, R. Saracci, R.
- Abstract
The European Prospective Investigation into Cancer and Nutrition (EPIC) is an ongoing multi-centre prospective cohort study designed to investigate the relationship between nutrition and cancer, with the potential for studying other diseases as well. The study currently includes 519 978 participants (366 521 women and 153457 men, mostly aged 35-70 years) in 23 centres located in 10 European countries, to be followed for cancer incidence and cause-specific mortality for several decades. At enrolment, which took place between 1992 and 2000 at each of the different centres, information was collected through a non-dietary questionnaire on lifestyle variables and through a dietary questionnaire addressing usual diet. Anthropometric measurements were performed and blood samples taken, from which plasma, serum, red cells and buffy coat fractions were separated and aliquoted for long-term storage, mostly in liquid nitrogen. To calibrate dietary measurements, a standardised, computer-assisted 24-hour dietary recall was implemented at each centre on stratified random samples of the participants, for a total of 36 900 subjects. EPIC represents the largest single resource available today world-wide for prospective investigations on the aetiology of cancers (and other diseases) that can integrate questionnaire data on lifestyle and diet, biomarkers of diet and of endogenous metabolism (e.g. hormones and growth factors) and genetic polymorphisms. First results of case-control studies nested within the cohort are expected early in 2003. The present paper provides a description of the EPIC study, with the aim of simplifying reference to it in future papers reporting substantive or methodological studies carried out in the EPIC cohort.
- Published
- 2002
10. Revisiting the Effects of Gender Diversity in Small Groups on Divergent Thinking: A Large-Scale Study Using Synchronous Electronic Brainstorming
- Author
-
Laurine Peter, Nicolas Michinov, Maud Besançon, Estelle Michinov, Jacques Juhel, Genavee Brown, Eric Jamet, Anthony Cherbonnier, ProFAN Consortium, Batruch Anatolia, Butera Fabrizio, Desrichard Olivier, Mella-Barraco Nathalie, Visintin Emilio Paolo, Brown Genavee, Bressan Marco, Poletti Céline, Régner Isabelle, Vives Eva, Bressoux Pascal, De Place Anne-Laure, Pansu Pascal, Riant Mathilde, Sanrey Camille, Cherbonnier Anthony, Goron Luc, Hemon Brivael, Jamet Eric, Michinov Estelle, Michinov Nicolas, Peter Laurine, Darnon Céline, Demolliens Marie, Huguet Pascal, Robert Anais, Stanczak Arnaud, Bouet Marinette, Cepeda Carlos, Ducros Théo, Martinez Ruben, Mazenod Vincent, Petitcollot Benoit, Toumani Farouk, and Vilmin Simon
- Subjects
gender diversity ,electronic brainstorming ,collaborative creativity ,idea generation ,divergent thinking ,“solo” groups ,Psychology ,BF1-990 - Abstract
Numerous studies have examined the effects of gender diversity in groups on creative performance, and no clear effect has been identified. Findings depend on situational cues making gender diversity more or less salient in groups. A large-scale study on two cohorts (N = 2,261) was conducted among business students to examine the impact of the gender diversity in small groups on divergent thinking in an idea-generation task performed by synchronous electronic brainstorming. Participants were automatically randomized in three- or four-member groups to generate ideas during 10 min on a gendered or neutral task. Then, five categories of groups where the proportion of men/women in groups varied from three/four men to three/four women were compared to examine creative performance on three divergent thinking measures (fluency, flexibility, and originality). A Multivariate Generalized Linear Mixed Model (mGLMM) showed greater fluency in all-women groups than in other groups (except mixed-gender groups composed of two men and two women), and more specifically “solo” groups composed of a single woman/man among a majority of men/women. For flexibility and originality, the superiority of all-women groups was found only in comparison to “solo” groups composed of a single woman. As gender differences are more salient in “solo” groups than in other groups faultlines may appear in groups, leading to a deleterious impact on creative performance.
- Published
- 2021
- Full Text
- View/download PDF
11. MUC1 est dérégulé par SNAIL1 dans un modèle rénal de transition épithélio-mésenchymateuse
- Author
-
Gnemmi, V., primary, Ringot, B., additional, Boulliez, A., additional, Hémon, B., additional, Zini, L., additional, Perrais, M., additional, Leroy, X., additional, and Aubert, S., additional
- Published
- 2011
- Full Text
- View/download PDF
12. MUC1 is a target of hypoxia-inducible factor transcription factor in renal clear carcinomatous cells
- Author
-
Perrais, M., primary, Aubert, S., additional, Hémon, B., additional, Porchet, N., additional, Leroy, X., additional, and Van Seuningen, I., additional
- Published
- 2008
- Full Text
- View/download PDF
13. C30 - Régulation de l’expression du gène de mucine MUC1 par les acides biliaires dans des modèles cellulaires et tissulaires humains d’adénocarcinome de l’œsophage
- Author
-
Piessen, G., primary, Mariette, C., additional, Leteurtre, E., additional, Hémon, B., additional, Aubert, J.P., additional, Triboulet, J.P., additional, and Van Seuningen, I., additional
- Published
- 2006
- Full Text
- View/download PDF
14. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection
- Author
-
Riboli, E, primary, Hunt, KJ, additional, Slimani, N, additional, Ferrari, P, additional, Norat, T, additional, Fahey, M, additional, Charrondière, UR, additional, Hémon, B, additional, Casagrande, C, additional, Vignat, J, additional, Overvad, K, additional, Tjønneland, A, additional, Clavel-Chapelon, F, additional, Thiébaut, A, additional, Wahrendorf, J, additional, Boeing, H, additional, Trichopoulos, D, additional, Trichopoulou, A, additional, Vineis, P, additional, Palli, D, additional, Bueno-de-Mesquita, HB, additional, Peeters, PHM, additional, Lund, E, additional, Engeset, D, additional, González, CA, additional, Barricarte, A, additional, Berglund, G, additional, Hallmans, G, additional, Day, NE, additional, Key, TJ, additional, Kaaks, R, additional, and Saracci, R, additional
- Published
- 2002
- Full Text
- View/download PDF
15. A singular path. The enclosure of Braine 'The Barn of the Monks' (Aisne) in the late La Tene period,Une trajectoire singulière les enclos de braine la grange des moines (Aisne) à la tene finale
- Author
-
Auxiette, G., Desenne, S., Bauvais, S., Gaudefroy, S., Gransar, F., Gratuze, B., Hémon, B., Hamon, C., Pinard, E., Pommepuy, C., Ruby, P., Sehier, E., Joëlle Rolland, Rossano, S., Pagès-Camagna, S., Carton, O., and Oboukhoff, S.
16. Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort
- Author
-
J. R. Quirós, Weimin Ye, Aurelio Barricarte, Petra H.M. Peeters, Isabelle Romieu, M-D Chirlaque, Hendrik B. Bueno-de-Mesquita, Verena Katzke, K. T. Khaw, Marc J. Gunter, Timothy J. Key, Paolo Vineis, Franck Carbonnel, Bertrand Hémon, H. Boeing, M. C. Boutron-Ruault, Claudia Agnoli, Rudolf Kaaks, Aurora Perez-Cornago, Eric J. Duell, D. Palli, Anne Laure Renault, M-J Sanchez, Salvatore Panico, Pilar Amiano, Marco Matejcic, R. Tumino, Sahar Yammine, Veronique Chajes, Miquel Porta, Tilman Kühn, Carlotta Sacerdote, Vinciane Rebours, Pekka Keski-Rahkonen, Antonia Trichopoulou, Elisabete Weiderpass, Fabienne Lesueur, Carine Biessy, Elio Riboli, Kuanrong Li, Noura Mebirouk, Matejcic, M, Lesueur, F, Biessy, C, Renault, A L, Mebirouk, N, Yammine, S, Keski-Rahkonen, P, Li, K, Hémon, B, Weiderpass, E, Rebours, V, Boutron-Ruault, M C, Carbonnel, F, Kaaks, R, Katzke, V, Kuhn, T, Boeing, H, Trichopoulou, A, Palli, D, Agnoli, C, Panico, S, Tumino, R, Sacerdote, LAURA LEA, Quirós, J R, Duell, E J, Porta, M, Sánchez, M J, Chirlaque, M D, Barricarte, A, Amiano, P, Ye, W, Peeters, P H, Khaw, K T, Perez-Cornago, A, Key, T J, Bueno-de-Mesquita, H B, Riboli, E, Vineis, P, Romieu, I, Gunter, M J, and Chajès, V
- Subjects
Male ,0301 basic medicine ,FOOD-INTAKE ,Cancer Research ,pancreatic cancer ,Gastroenterology ,Cohort Studies ,chemistry.chemical_compound ,0302 clinical medicine ,Phospholipids ,ASSOCIATIONS ,chemistry.chemical_classification ,INDUCTION ,Incidence ,Middle Aged ,European Prospective Investigation into Cancer and Nutrition ,Europe ,Oncology ,030220 oncology & carcinogenesis ,Cohort ,F344 RATS ,biomarker ,GROWTH ,NUTRITION ,Female ,Heptadecanoic acid ,HEALTH ,Docosapentaenoic acid ,Life Sciences & Biomedicine ,Polyunsaturated fatty acid ,Adult ,Risk ,medicine.medical_specialty ,CARCINOMA ,plasma phospholipids ,Lower risk ,fatty acids ,OVARIAN-CANCER ,DIET ,03 medical and health sciences ,Pancreatic cancer ,Internal medicine ,medicine ,Humans ,1112 Oncology and Carcinogenesis ,Oncology & Carcinogenesis ,tobacco smoking ,Aged ,Science & Technology ,030109 nutrition & dietetics ,business.industry ,plasma phospholipid ,biomarkers ,Odds ratio ,medicine.disease ,Pancreatic Neoplasms ,chemistry ,Case-Control Studies ,fatty acid ,business - Abstract
There are both limited and conflicting data on the role of dietary fat and specific fatty acids in the development of pancreatic cancer. In this study, we investigated the association between plasma phospholipid fatty acids and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. The fatty acid composition was measured by gas chromatography in plasma samples collected at recruitment from 375 incident pancreatic cancer cases and 375 matched controls. Associations of specific fatty acids with pancreatic cancer risk were evaluated using multivariable conditional logistic regression models with adjustment for established pancreatic cancer risk factors. Statistically significant inverse associations were found between pancreatic cancer incidence and levels of heptadecanoic acid (ORT3-T1 [odds ratio for highest versus lowest tertile] =0.63; 95%CI[confidence interval]=0.41-0.98; Ptrend =0.036), n-3 polyunsaturated α-linolenic acid (ORT3-T1 =0.60; 95%CI=0.39-0.92; Ptrend =0.02) and docosapentaenoic acid (ORT3-T1 =0.52; 95%CI=0.32-0.85; Ptrend =0.008). Industrial trans-fatty acids were positively associated with pancreatic cancer risk among men (ORT3-T1 =3.00; 95%CI=1.13-7.99; Ptrend =0.029), while conjugated linoleic acids were inversely related to pancreatic cancer among women only (ORT3-T1 =0.37; 95%CI=0.17-0.81; Ptrend =0.008). Among current smokers, the long-chain n-6/n-3 polyunsaturated fatty acids ratio was positively associated with pancreatic cancer risk (ORT3-T1 =3.40; 95%CI=1.39-8.34; Ptrend =0.007). Results were robust to a range of sensitivity analyses. Our findings suggest that higher circulating levels of saturated fatty acids with an odd number of carbon atoms and n-3 polyunsaturated fatty acids may be related to lower risk of pancreatic cancer. The influence of some fatty acids on the development of pancreatic cancer may be sex-specific and modulated by smoking. This article is protected by copyright. All rights reserved.
- Published
- 2018
17. Sources of pre-analytical variations in yield of DNA extracted from blood samples: analysis of 50,000 DNA samples in EPIC
- Author
-
Domenico Palli, Bertrand Hémon, Petra H.M. Peeters, Guri Skeie, Gilles Ferro, Pierre Hainaut, Françoise Clavel-Chapelon, Karina Standahl Olsen, Amy Hutchinson, Carine Biessy, Elio Riboli, Afshan Siddiq, Antonia Trichopoulou, Pagona Lagiou, Christophe Lallemand, Nicholas J. Wareham, Federico Canzian, Heiner Boeing, Anne Boland, Claudia Agnoli, Roberto Bilbao, Elodie Caboux, Eiliv Lund, Ruth C. Travis, Carmen Navarro, Maimuna Mendy, Núria Sala, Laure Dossus, Eva Fisher, Dimitrios Trichopoulos, Aurelio Barricarte, Yvonne T. van der Schouw, Maria Luisa Redondo, H. Bas Bueno-de-Mesquita, Isabelle Romieu, Rosario Tumino, Marie-Christine Boutron-Ruault, Salvatore Panico, Abigail Britten, Paolo Vineis, Silvia Polidoro, Mark J. Gunter, Sabina Rinaldi, María José Sánchez, Matthew A. Sims, International Prevention Research Institute (IPRI), Caboux, E, Lallemand, C, Ferro, G, H?mon, B, Mendy, M, Biessy, C, Sims, M, Wareham, N, Britten, A, Boland, A, Hutchinson, A, Siddiq, A, Vineis, P, Riboli, E, Romieu, I, Rinaldi, S, Gunter, Mj, Peeters, Ph, van der Schouw, Yt, Travis, R, Bueno de Mesquita, Hb, Canzian, F, S?nchez, Mj, Skeie, G, Olsen, K, Lund, E, Bilbao, R, Sala, N, Barricarte, A, Palli, D, Navarro, C, Panico, Salvatore, Redondo, Ml, Polidoro, S, Dossus, L, Boutron Ruault, Mc, Clavel Chapelon, F, Trichopoulou, A, Trichopoulos, D, Lagiou, P, Boeing, H, Fisher, E, Tumino, R, Agnoli, C, Hainaut, P., [Caboux,E, Lallemand,C, Ferro,G, Hémon,B, Mendy,M, Biessy,C, Romieu,I, Rinaldi,S] International Agency for Research on Cancer, Lyon, France. [Sims,M, Wareham,N, Britten,A] Medical Research Council (MRC) Epidemiology Unit, Addenbrooke’s Hospital, Cambridge, United Kingdom. [Boland,A] Centre National de Génotypage, Institut Génomique, Commissariat à l’énergie Atomique, Evry, France. [Hutchinson,A] Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America. [Siddiq,A, Vineis,P, Riboli,E, Gunter,MJ, Peeters,PHM] Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom. [Peeters,PHM, Schouw,T] Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. [Travis,R[ Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom. [Bueno-de-Mesquita,HB] National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands. [Canzian,F] Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. [Sánchez,M] Andalusian School of Public Health, Granada (Spain) and CIBER de Epidemiología y Salud Pública (CIBERESP), Granada, Spain. [Skeie,G, Olsen,KS, Lund,E] Institute of Community Medicine, University of Tromsø, Tromsø, Norway. [Bilbao,R] Fundación Vasca de Innovación e Investigación Sanitarias, Sondika, Bizkaia, Spain. [Sala,N] Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO)-IDIBELL, Barcelona, Spain. [Barricarte,A] Navarre Public Health Institute, Pamplona, Spain. [Barricarte,A, Navarro,C] Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública-CIBERESP), Madrid, Spain. [Hainaut,P] International Prevention Research Institute, Lyon, France. [Palli,D] Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute – ISPO, Florence, Italy. [Navarro,C] Department of Epidemiology, Regional Health Authority, Murcia, Spain. [Panico,S] Department of clinical and experimental medicine, Federico ii University, Naples, Italy. [Redondo,ML] Public Health Directorate, Asturias, Spain. [Polidoro,S] Human Genetics Foundation-HuGeF, Turin, Italy. [Dossus,L, Boutron-Ruault,MC, Clavel-Chapelon,F] INSERM U1018, Gustave Roussy Institute, Paris South University, Villejuif, France. [Trichopoulou,A, Lagiou,P] Department of Hygiene, Epidemiology and Medical Statistics, Medical School, World Health Organization (WHO) Collaborating Center for Food and Nutrition Policies, University of Athens, Goudi, Athens, Greece. [Trichopoulou,A, Trichopoulos,D] Hellenic Health Foundation, Athens, Greece. [Trichopoulos,D, Lagiou,P] Department of Epidemiology, Harvard School of Public Health, Massachusetts, Boston, United States of America. Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece. [Boeing,H] Potsdam-Rehbrücke Department of Epidemiology, German Institute of Human Nutrition (DIfE), Nuthetal, Germany. [Fisher,E] Administrative Office of the Commission on Genetic Testing Robert Koch-Institute, Berlin, Germany. [Tumino,R] Cancer Registry and Histopathology Unit, ‘‘Civile M. P. Arezzo’’ Hospital, Ragusa, Italy. [Agnoli,C] Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Funding: The study was funded by European Commission Research & Innovation DG project BBMRI (Biobanking and Biomolecular Resources Research Infrastructure,http://www.bbmri.eu), project number 212111 and by the Regular Budget of International Agency for Research on Cancer (IARC). DNA extraction data used in the study were generated as part of molecular epidemiological studies approved by the Steering Committee of the European Prospective Investigation into Cancer and Nutrition (EPIC, http://epic.iarc.fr). Detailed information about the funding of EPIC is available at http://epic.iarc.fr/funding.php. The funding agencies and organizations which provided funds for DNA extraction in specific EPIC studies were Imperial College London (ICL, BRCD study), Medical Research Council UK (MRC UK, EPHD study), European Community INTERACT project (through MRC Cambridge, UK, INT study, http://www.inter-act.eu), International Agency for Research on Cancer (IARC) and Imperial College London (ICL) (LUND study), EU FP6 Network of Excellence Environmental Cancer Risk, Nutrition and Individual Susceptibility (ECNIS, http:// www.ecnis.org), and and Cancer Research UK (CRCUK) (LYMD study).
- Subjects
Male ,Erythrocytes ,Genotyping Techniques ,Epidemiology ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Errors::Observer Variation [Medical Subject Headings] ,ADN ,Genome-wide association study ,Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings] ,Biochemistry ,Body Mass Index ,Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings] ,Anatomy::Cells::Blood Cells::Erythrocytes [Medical Subject Headings] ,0302 clinical medicine ,Prospective Studies ,lcsh:Science ,Càncer ,Cancer ,0303 health sciences ,Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Epidemiologic Factors::Age Factors [Medical Subject Headings] ,Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Epidemiologic Factors::Sex Factors [Medical Subject Headings] ,Genomics ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Specimen Handling [Medical Subject Headings] ,3. Good health ,SNP genotyping ,030220 oncology & carcinogenesis ,Science & Technology - Other Topics ,Medicine ,Cellular Types ,Genotyping ,Anciano ,Psychiatry and Psychology::Behavior and Behavior Mechanisms::Behavior::Habits::Smoking [Medical Subject Headings] ,Check Tags::Male [Medical Subject Headings] ,Specimen Handling ,Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Hemolysis [Medical Subject Headings] ,03 medical and health sciences ,Cryobiology ,AGE ,Named Groups::Persons::Age Groups::Adult [Medical Subject Headings] ,Genetics ,Genome-Wide Association Studies ,QUALITY ,Humans ,Biology ,Aged ,Science & Technology ,Blood Cells ,lcsh:R ,Computational Biology ,DNA ,Biotechnology ,Check Tags::Female [Medical Subject Headings] ,Case-Control Studies ,Leukocytes, Mononuclear ,lcsh:Q ,Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids::DNA [Medical Subject Headings] ,Índice de Masa Corporal ,lcsh:Medicine ,Cancer risk ,Nucleic Acids ,Molecular Cell Biology ,GENOME WIDE ,RISK ,2. Zero hunger ,Observer Variation ,Multidisciplinary ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies [Medical Subject Headings] ,Smoking ,Age Factors ,Middle Aged ,Haemolysis ,Nutrition Surveys ,CANCER ,European Prospective Investigation into Cancer and Nutrition ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Research Design::Reproducibility of Results [Medical Subject Headings] ,Multidisciplinary Sciences ,CELL COUNT ,Genetic Epidemiology ,SEX ,Female ,Research Article ,Factores de Edad ,Adult ,VDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Medisinsk genetikk: 714 ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Prospective Studies [Medical Subject Headings] ,Clinical Research Design ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Physical Examination::Body Constitution::Body Weights and Measures::Body Mass Index [Medical Subject Headings] ,VDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Medical genetics: 714 ,Hemolysis ,Adult Age Factors Aged Body Mass Index Case-Control Studies DNA/blood/*isolation & purification Erythrocytes/chemistry Female Genotyping Techniques Hemolysis Humans Leukocytes ,Sex Factors ,Named Groups::Persons::Age Groups::Adult::Aged [Medical Subject Headings] ,Nutrició ,030304 developmental biology ,Nutrition ,Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Genetic Techniques::Genotyping Techniques [Medical Subject Headings] ,Population Biology ,business.industry ,Anatomy::Cells::Blood Cells::Leukocytes::Leukocytes, Mononuclear [Medical Subject Headings] ,Reproducibility of Results ,DNA extraction ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Mononuclear/*chemistry Male Middle Aged Observer Variation Prospective Studies Reproducibility of Results Sex Factors Smoking Specimen Handling/*standards ,business - Abstract
The European Prospective Investigation into Cancer and nutrition (EPIC) is a long-term, multi-centric prospective study in Europe investigating the relationships between cancer and nutrition. This study has served as a basis for a number of Genome-Wide Association Studies (GWAS) and other types of genetic analyses. Over a period of 5 years, 52,256 EPIC DNA samples have been extracted using an automated DNA extraction platform. Here we have evaluated the pre-analytical factors affecting DNA yield, including anthropometric, epidemiological and technical factors such as center of subject recruitment, age, gender, body-mass index, disease case or control status, tobacco consumption, number of aliquots of buffy coat used for DNA extraction, extraction machine or procedure, DNA quantification method, degree of haemolysis and variations in the timing of sample processing. We show that the largest significant variations in DNA yield were observed with degree of haemolysis and with center of subject recruitment. Age, gender, body-mass index, cancer case or control status and tobacco consumption also significantly impacted DNA yield. Feedback from laboratories which have analyzed DNA with different SNP genotyping technologies demonstrate that the vast majority of samples (approximately 88%) performed adequately in different types of assays. To our knowledge this study is the largest to date to evaluate the sources of pre-analytical variations in DNA extracted from peripheral leucocytes. The results provide a strong evidence-based rationale for standardized recommendations on blood collection and processing protocols for large-scale genetic studies. The study was funded by European Commission Research & Innovation DG project BBMRI (Biobanking and Biomolecular Resources Research Infrastructure, http://www.bbmri.eu), project number 212111 and by the Regular Budget of International Agency for Research on Cancer (IARC). DNA extraction data used in the study were generated as part of molecular epidemiological studies approved by the Steering Committee of the European Prospective Investigation into Cancer and Nutrition (EPIC, http://epic.iarc.fr). Detailed information about the funding of EPIC is available at http://epic.iarc.fr/funding.php. The funding agencies and organizations which provided funds for DNA extraction in specific EPIC studies were Imperial College London (ICL, BRCD study); Medical Research Council UK (MRC UK, EPHD study); European Community INTERACT project (through MRC Cambridge, UK, INT study, http://www.inter-act.eu); International Agency for Research on Cancer (IARC) and Imperial College London (ICL) (LUND study), EU FP6 Network of Excellence Environmental Cancer Risk, Nutrition and Individual Susceptibility (ECNIS, http:// www.ecnis.org); and Cancer Research UK (CRCUK) (LYMD study).
- Published
- 2012
- Full Text
- View/download PDF
18. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition
- Author
-
Alban Fabre, Mandy Schulz, Franco Berrino, Sheila Bingham, Marit Waaseth, F. Clavel-Chapelon, Carlos González, Rudolf Kaaks, Giovanna Masala, Sabina Rinaldi, Laudina Rodríguez, Valentina Gallo, Naomi E. Allen, Elio Riboli, Kjersti Bakken, Veronique Chajes, Salvatore Panico, Gillian K Reeves, Annika Steffen, Rosario Tumino, Teresa Norat, Anne Tjønneland, María José Sánchez, Agnès Fournier, Nadia Slimani, Pilar Amiano Etxezarreta, Bertrand Hémon, Carla H. van Gils, Vanessa Dumeaux, Eva Ardanaz, Jenny Chang-Claude, María José Tormo, Petra H.M. Peeters, Anja Olsen, Kay-Tee Khaw, Eiliv Lund, Bakken, K, Fournier, A, Lund, E, Waaseth, M, Dumeaux, V, Clavel Chapelon, F, Fabre, A, Hémon, B, Rinaldi, S, Chajes, V, Slimani, N, Allen, Ne, Reeves, Gk, Bingham, S, Khaw, Kt, Olsen, A, Tjønneland, A, Rodriguez, L, Sánchez, Mj, Etxezarreta, Pa, Ardanaz, E, Tormo, Mj, Peeters, Ph, van Gils, Ch, Steffen, A, Schulz, M, Chang Claude, J, Kaaks, R, Tumino, R, Gallo, V, Norat, T, Riboli, E, Panico, Salvatore, Masala, G, González, Ca, and Berrino, F.
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,medicine.medical_treatment ,Denmark ,Breast Neoplasms ,Breast cancer ,Risk Factors ,Internal medicine ,Germany ,Surveys and Questionnaires ,medicine ,Humans ,Prospective Studies ,Registries ,Risk factor ,Aged ,Netherlands ,Proportional Hazards Models ,Gynecology ,Sweden ,Greece ,business.industry ,Norway ,Estrogen Replacement Therapy ,Cancer ,Hormone replacement therapy (menopause) ,Middle Aged ,medicine.disease ,United Kingdom ,European Prospective Investigation into Cancer and Nutrition ,Europe ,Postmenopause ,Regimen ,Italy ,Spain ,Relative risk ,Breast disease ,France ,business ,Follow-Up Studies - Abstract
Menopausal hormone therapy (MHT) is characterized by use of different constituents, regimens and routes of administration. We investigated the association between the use of different types of MHT and breast cancer risk in the EPIC cohort study. The analysis is based on data from 133,744 postmenopausal women. Approximately 133,744 postmenopausal women contributed to this analysis. Information on MHT was derived from country-specific self-administered questionnaires with a single baseline assessment. Incident breast cancers were identified through population cancer registries or by active follow-up (mean: 8.6 yr). Overall relative risks (RR) and 95% confidence interval (CI) were derived from country-specific Cox proportional hazard models estimates. A total of 4312 primary breast cancers were diagnosed during 1,153,747 person-years of follow-up. Compared with MHT never users, breast cancer risk was higher among current users of estrogen only (RR: 1.42, 95% CI 1.23-1.64) and higher still among current users of combined MHT (RR: 1.77, 95% CI 1.40-2.24; p = 0.02 for combined vs. estrogen-only). Continuous combined regimens conferred a 43% (95% CI: 19-72%) greater risk compared with sequential regimens. There was no significant difference between progesterone and testosterone derivatives in sequential regimens. There was no significant variation in risk linked to the estrogenic component of MHT, neither for oral vs. cutaneous administration nor for estradiol compounds vs. conjugated equine estrogens. Estrogen-only and combined MHT uses were associated with increased breast cancer risk. Continuous combined preparations were associated with the highest risk. Further studies are needed to disentangle the effects of the regimen and the progestin component.
- Published
- 2010
19. Ultra-processed foods, adiposity and risk of head and neck cancer and oesophageal adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition study: a mediation analysis.
- Author
-
Morales-Berstein F, Biessy C, Viallon V, Goncalves-Soares A, Casagrande C, Hémon B, Kliemann N, Cairat M, Blanco Lopez J, Al Nahas A, Chang K, Vamos E, Rauber F, Bertazzi Levy R, Barbosa Cunha D, Jakszyn P, Ferrari P, Vineis P, Masala G, Catalano A, Sonestedt E, Borné Y, Katzke V, Bajracharya R, Agnoli C, Guevara M, Heath A, Radoï L, Mancini F, Weiderpass E, Huerta JM, Sánchez MJ, Tjønneland A, Kyrø C, Schulze MB, Skeie G, Lukic M, Braaten T, Gunter M, Millett C, Agudo A, Brennan P, Borges MC, Richmond RC, Richardson TG, Davey Smith G, Relton CL, and Huybrechts I
- Subjects
- Humans, Adiposity, Prospective Studies, Food, Processed, Mediation Analysis, Obesity, Fast Foods adverse effects, Diet, Food Handling, Head and Neck Neoplasms, Adenocarcinoma epidemiology, Adenocarcinoma etiology, Esophageal Neoplasms
- Abstract
Purpose: To investigate the role of adiposity in the associations between ultra-processed food (UPF) consumption and head and neck cancer (HNC) and oesophageal adenocarcinoma (OAC) in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort., Methods: Our study included 450,111 EPIC participants. We used Cox regressions to investigate the associations between the consumption of UPFs and HNC and OAC risk. A mediation analysis was performed to assess the role of body mass index (BMI) and waist-to-hip ratio (WHR) in these associations. In sensitivity analyses, we investigated accidental death as a negative control outcome., Results: During a mean follow-up of 14.13 ± 3.98 years, 910 and 215 participants developed HNC and OAC, respectively. A 10% g/d higher consumption of UPFs was associated with an increased risk of HNC (hazard ratio [HR] = 1.23, 95% confidence interval [CI] 1.14-1.34) and OAC (HR = 1.24, 95% CI 1.05-1.47). WHR mediated 5% (95% CI 3-10%) of the association between the consumption of UPFs and HNC risk, while BMI and WHR, respectively, mediated 13% (95% CI 6-53%) and 15% (95% CI 8-72%) of the association between the consumption of UPFs and OAC risk. UPF consumption was positively associated with accidental death in the negative control analysis., Conclusions: We reaffirmed that higher UPF consumption is associated with greater risk of HNC and OAC in EPIC. The proportion mediated via adiposity was small. Further research is required to investigate other mechanisms that may be at play (if there is indeed any causal effect of UPF consumption on these cancers)., (© 2023. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
20. Protective resources against stress among student nurses: Influences of self-efficacy, emotional intelligence and conflict management styles.
- Author
-
Michinov E, Robin G, Hémon B, Béranger R, and Boissart M
- Subjects
- Male, Humans, Female, Adaptation, Psychological, Cross-Sectional Studies, Emotional Intelligence, Surveys and Questionnaires, Self Efficacy, Students, Nursing psychology, Psychological Tests, Self Report
- Abstract
Aims: This study aimed to investigate the levels of stress among French student nurses and the influence of different personal resources on their well-being and stress levels., Background: Student nurses have to cope with strong emotional demands, leading them to experience academic stress. Recent studies have highlighted the influence of personal resources such as self-efficacy, conflict management styles and emotional intelligence on the ability to cope with stressful situations. However, the contributions of these different factors have so far been explored separately., Design: A multicenter cross-sectional survey was performed from February to April 2022. The sample consisted of 1021 first-year student nurses from different nursing schools in France (including 890 women and 113 men), aged 18-55 years., Methods: Students completed an online questionnaire containing measures of well-being, Perceived Stress Scale, Occupational Stress, Generalized Self-Efficacy Scale, Emotional Intelligence and Conflict Management Styles., Results: Nearly half (40.4%) of participants reported experiencing symptoms of stress. However, they also reported a satisfactory well-being and high self-efficacy for coping with stressful situations. Multiple regression analyses revealed major contributions of self-efficacy to stress and well-being and additional mediation models showed that these contributions were partially mediated by awareness of one's own and others' emotions., Conclusions: These findings highlight the importance of continuing to work on the construction of appropriate educational activities that are consistent with the technical and, above all, nontechnical skills of student nurses., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
21. Fruit consumption and the risk of bladder cancer: A pooled analysis by the Bladder Cancer Epidemiology and Nutritional Determinants Study.
- Author
-
Jochems SHJ, Reulen RC, van Osch FHM, Witlox WJA, Goossens ME, Brinkman M, Giles GG, Milne RL, van den Brandt PA, White E, Weiderpass E, Huybrechts I, Hémon B, Agudo A, Bueno-de-Mesquita B, Cheng KK, van Schooten FJ, Bryan RT, Wesselius A, and Zeegers MP
- Subjects
- Cohort Studies, Female, Follow-Up Studies, Fruit, Humans, Male, Middle Aged, Proportional Hazards Models, Risk Factors, Smoking adverse effects, Urinary Bladder pathology, Urinary Bladder Neoplasms pathology, Urinary Bladder Neoplasms epidemiology, Urinary Bladder Neoplasms etiology
- Abstract
While the association between fruit consumption and bladder cancer risk has been extensively reported, studies have had inadequate statistical power to investigate associations between types of fruit and bladder cancer risk satisfactorily. Fruit consumption in relation to bladder cancer risk was investigated by pooling individual data from 13 cohort studies. Cox regression models with attained age as time scale were used to estimate hazard ratios (HRs) for intakes of total fruit and citrus fruits, soft fruits, stone fruits, tropical fruits, pome fruits and fruit products. Analyses were stratified by sex, smoking status and bladder cancer subtype. During on average 11.2 years of follow-up, 2836 individuals developed incident bladder cancer. Increasing fruit consumption (by 100 g/day) was inversely associated with the risk of bladder cancer in women (HR = 0.92; 95% CI 0.85-0.99). Although in women the association with fruit consumption was most evident for higher-risk nonmuscle invasive bladder cancer (NMIBC; HR = 0.72; 95% CI 0.56-0.92), the test for heterogeneity by bladder cancer subtype was nonsignificant (P-heterogeneity = .14). Increasing fruit consumption (by 100 g/day) was not associated with bladder cancer risk in men (HR = 0.99; 95% CI 0.94-1.03), never smokers (HR = 0.96; 95% CI 0.88-1.05), former smokers (HR = 0.98; 95% CI 0.92-1.05) or current smokers (HR = 0.95; 95% CI 0.89-1.01). The consumption of any type of fruit was not found to be associated with bladder cancer risk (P values > .05). Our study supports no evidence that the consumption of specific types of fruit reduces the risk of bladder cancer. However, increasing total fruit consumption may reduce bladder cancer risk in women., (© 2020 UICC.)
- Published
- 2020
- Full Text
- View/download PDF
22. Relationships Between Expertise, Crew Familiarity and Surgical Workflow Disruptions: An Observational Study.
- Author
-
Henaux PL, Michinov E, Rochat J, Hémon B, Jannin P, and Riffaud L
- Subjects
- Adult, Cervical Vertebrae surgery, Clinical Competence, Cooperative Behavior, Diskectomy methods, Elective Surgical Procedures standards, Humans, Middle Aged, Nurses standards, Operating Rooms organization & administration, Operating Rooms standards, Patient Care Team organization & administration, Spinal Fusion methods, Surgeons standards, Video Recording, Diskectomy standards, Patient Care Team standards, Physician-Nurse Relations, Spinal Fusion standards, Workflow
- Abstract
Background: Teamwork is an essential factor in reducing workflow disruption (WD) in the operating room. Team familiarity (TF) has been recognized as an antecedent to surgical quality and safety. To date, no study has examined the link between team members' role and expertise, TF and WD in surgical setting. This study aimed to examine the relationships between expertise, surgeon-scrub nurse familiarity and WD., Methods: We observed a convenience sample of 12 elective neurosurgical procedures carried out by 4 surgeons and 11 SN with different levels of expertise and different degrees of familiarity between surgeons and SN. We calculated the number of WD per unit of coding time to control for the duration of operation. We explored the type and frequency of WD, and the differences between the surgeons and SN. We examined the relationships between duration of WD, staff expertise and surgeon-scrub nurse familiarity., Results: 9.91% of the coded surgical time concerned WD. The most frequent causes of WD were distractions (29.7%) and colleagues' interruptions (25.2%). This proportion was seen for SN, whereas teaching moments and colleagues' interruptions were the most frequent WD for surgeons. The WD was less high among expert surgeons and less frequent when surgeon was familiar with SN., Conclusions: The frequency of WD during surgical time can compromise surgical quality and patient safety. WD seems to decrease in teams with high levels of surgeon-scrub nurse familiarity and with development of surgical expertise. Favoring TF and giving feedback to the team about WD issues could be interesting ways to improve teamwork.
- Published
- 2019
- Full Text
- View/download PDF
23. Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma.
- Author
-
Gaudelot K, Gibier JB, Pottier N, Hémon B, Van Seuningen I, Glowacki F, Leroy X, Cauffiez C, Gnemmi V, Aubert S, and Perrais M
- Subjects
- Antagomirs genetics, Apoptosis drug effects, Benzimidazoles administration & dosage, Carcinoma, Renal Cell genetics, Carcinoma, Renal Cell pathology, Cell Line, Tumor, Cell Proliferation genetics, Copper Transporter 1, Drug Resistance, Neoplasm genetics, Fluorouracil administration & dosage, Gene Expression Regulation, Neoplastic drug effects, Humans, Organic Cation Transporter 2, Organoplatinum Compounds administration & dosage, Oxaliplatin, Paclitaxel administration & dosage, Quinolones administration & dosage, Signal Transduction, Carcinoma, Renal Cell drug therapy, Cation Transport Proteins biosynthesis, MicroRNAs genetics, Organic Cation Transport Proteins biosynthesis, Organic Cation Transporter 1 biosynthesis
- Abstract
Renal cell carcinoma, the most common neoplasm of adult kidney, accounts for about 3% of adult malignancies and is usually highly resistant to conventional therapy. MicroRNAs are a class of small non-coding RNAs, which have been previously shown to promote malignant initiation and progression. In this study, we focused our attention on miR-21, a well described oncomiR commonly upregulated in cancer. Using a cohort of 99 primary renal cell carcinoma samples, we showed that miR-21 expression in cancer tissues was higher than in adjacent non-tumor tissues whereas no significant difference was observed with stages, grades, and metastatic outcome. In vitro, miR-21 was also overexpressed in renal carcinoma cell lines compared to HK-2 human proximal tubule epithelial cell line. Moreover, using Boyden chambers and western blot techniques, we also showed that miR-21 overexpression increased migratory, invasive, proliferative, and anti-apoptotic signaling pathways whereas opposite results were observed using an anti-miR-21-based silencing strategy. Finally, we assessed the role of miR-21 in mediating renal cell carcinoma chemoresistance and further showed that miR-21 silencing significantly (1) increased chemosensitivity of paclitaxel, 5-fluorouracil, oxaliplatin, and dovitinib; (2) decreased expression of multi-drug resistance genes; and (4) increased SLC22A1/OCT1, SLC22A2/OCT2, and SLC31A1/CTR1 platinum influx transporter expression. In conclusion, our results showed that miR-21 is a key actor of renal cancer progression and plays an important role in the resistance to chemotherapeutic drugs. In renal cell carcinoma, targeting miR-21 is a potential new therapeutic strategy to improve chemotherapy efficacy and consequently patient outcome.
- Published
- 2017
- Full Text
- View/download PDF
24. Dual role of MUC1 mucin in kidney ischemia-reperfusion injury: Nephroprotector in early phase, but pro-fibrotic in late phase.
- Author
-
Gibier JB, Hémon B, Fanchon M, Gaudelot K, Pottier N, Ringot B, Van Seuningen I, Glowacki F, Cauffiez C, Blum D, Copin MC, Perrais M, and Gnemmi V
- Subjects
- Animals, Fibrosis, HEK293 Cells, Humans, Kidney Diseases genetics, Kidney Diseases pathology, Kidney Tubules pathology, Mice, Mice, Knockout, Mucin-1 genetics, Reperfusion Injury genetics, Reperfusion Injury pathology, Kidney Diseases metabolism, Kidney Tubules metabolism, Mucin-1 metabolism, Reperfusion Injury metabolism
- Abstract
Acute kidney injury (AKI) is characterized by acute tubular necrosis (ATN) which involves mainly proximal tubules. Past AKI is associated with higher risk of chronic kidney disease (CKD). The MUC1 mucin is a large glycoprotein responsible for epithelial protection and locates to convoluted distal tubules and collecting ducts. Since MUC1 activates the epithelial-mesenchymal transition (EMT) in carcinoma cells, we hypothesized that MUC1 could be involved in epithelial tubular cell plasticity, a process that not only accompanies epithelial repair, but also participates into kidney fibrosis, histological substratum of CKD. In cultured human proximal cells and in human kidney allograft biopsies, we observed MUC1 induction in proximal tubules displaying ATN. Transient MUC1 induction localized with mesenchymal and stem-cell markers and was associated in vitro with reduced anoikis. In a mouse ischemia-reperfusion (IR) model, Muc1 expression mitigates severe tubular injury, as WT displayed less ATN than Muc1 KO mice. But, WT mice displayed more severe kidney fibrosis than Muc1 KO 28days after ischemia. Besides, sustained Muc1 expression in WT was associated with less kidney M2 macrophages. Human kidney biopsies performed within the first week (W1) of transplantation in the context of IR showed MUC1 W1 induction associated with EMT markers. Protocol biopsies performed 3months after demonstrated sustained abnormal MUC1 induction in atrophic tubules within kidney fibrosis. Altogether these data showed that sustained abnormal MUC1 induction accompanies failing epithelial repair, chronic inflammation and kidney fibrosis. In conclusion, MUC1 exerts opposite effects during kidney response to IR: first protective and then harmful., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
25. Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
- Author
-
Zamora-Ros R, Knaze V, Rothwell JA, Hémon B, Moskal A, Overvad K, Tjønneland A, Kyrø C, Fagherazzi G, Boutron-Ruault MC, Touillaud M, Katzke V, Kühn T, Boeing H, Förster J, Trichopoulou A, Valanou E, Peppa E, Palli D, Agnoli C, Ricceri F, Tumino R, de Magistris MS, Peeters PH, Bueno-de-Mesquita HB, Engeset D, Skeie G, Hjartåker A, Menéndez V, Agudo A, Molina-Montes E, Huerta JM, Barricarte A, Amiano P, Sonestedt E, Nilsson LM, Landberg R, Key TJ, Khaw KT, Wareham NJ, Lu Y, Slimani N, Romieu I, Riboli E, and Scalbert A
- Subjects
- Adult, Aged, Body Mass Index, Coffee chemistry, Cross-Sectional Studies, Europe, Exercise, Female, Flavonoids administration & dosage, Food Analysis, Food Handling, Fruit chemistry, Humans, Hydroxybenzoates administration & dosage, Life Style, Male, Mental Recall, Middle Aged, Proanthocyanidins administration & dosage, Prospective Studies, Socioeconomic Factors, Tea chemistry, Diet, Nutrition Assessment, Polyphenols administration & dosage
- Abstract
Background/objectives: Polyphenols are plant secondary metabolites with a large variability in their chemical structure and dietary occurrence that have been associated with some protective effects against several chronic diseases. To date, limited data exist on intake of polyphenols in populations. The current cross-sectional analysis aimed at estimating dietary intakes of all currently known individual polyphenols and total intake per class and subclass, and to identify their main food sources in the European Prospective Investigation into Cancer and Nutrition cohort., Methods: Dietary data at baseline were collected using a standardized 24-h dietary recall software administered to 36,037 adult subjects. Dietary data were linked with Phenol-Explorer, a database with data on 502 individual polyphenols in 452 foods and data on polyphenol losses due to cooking and food processing., Results: Mean total polyphenol intake was the highest in Aarhus-Denmark (1786 mg/day in men and 1626 mg/day in women) and the lowest in Greece (744 mg/day in men and 584 mg/day in women). When dividing the subjects into three regions, the highest intake of total polyphenols was observed in the UK health-conscious group, followed by non-Mediterranean (non-MED) and MED countries. The main polyphenol contributors were phenolic acids (52.5-56.9 %), except in men from MED countries and in the UK health-conscious group where they were flavonoids (49.1-61.7 %). Coffee, tea, and fruits were the most important food sources of total polyphenols. A total of 437 different individual polyphenols were consumed, including 94 consumed at a level >1 mg/day. The most abundant ones were the caffeoylquinic acids and the proanthocyanidin oligomers and polymers., Conclusion: This study describes the large number of dietary individual polyphenols consumed and the high variability of their intakes between European populations, particularly between MED and non-MED countries.
- Published
- 2016
- Full Text
- View/download PDF
26. MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter.
- Author
-
Gnemmi V, Bouillez A, Gaudelot K, Hémon B, Ringot B, Pottier N, Glowacki F, Villers A, Vindrieux D, Cauffiez C, Van Seuningen I, Bernard D, Leroy X, Aubert S, and Perrais M
- Subjects
- Carcinoma, Renal Cell genetics, Cell Line, Tumor, Cell Nucleus metabolism, Epithelial-Mesenchymal Transition, HEK293 Cells, Humans, Kidney Neoplasms genetics, Mucin-1 genetics, Promoter Regions, Genetic, RNA, Messenger biosynthesis, RNA, Messenger genetics, Snail Family Transcription Factors, Transcription Factors genetics, Transcriptional Activation, Up-Regulation, Wnt Signaling Pathway, Carcinoma, Renal Cell metabolism, Carcinoma, Renal Cell pathology, Kidney Neoplasms metabolism, Kidney Neoplasms pathology, Mucin-1 biosynthesis, Transcription Factors biosynthesis, Wnt Proteins metabolism, beta Catenin metabolism
- Abstract
MUC1 is overexpressed in human carcinomas. The transcription factor SNAIL can activate epithelial-mesenchymal transition (EMT) in cancer cells. In this study, in renal carcinoma, we demonstrate that (i) MUC1 and SNAIL were overexpressed in human sarcomatoid carcinomas, (ii) SNAIL increased indirectly MUC1 expression, (iii) MUC1 overexpression induced EMT, (iv) MUC1 C-terminal domain (MUC1-C) and β-catenin increased SNAIL transcriptional activity by interaction with its promoter and (v) blocking MUC1-C nuclear localization decreased Wnt/β-catenin signaling pathway activation and SNAIL expression. Altogether, our findings demonstrate that MUC1 is an actor in EMT and appears as a new therapeutic target., (Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
27. MUC1-C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma secretase dependent pathway.
- Author
-
Bouillez A, Gnemmi V, Gaudelot K, Hémon B, Ringot B, Pottier N, Glowacki F, Butruille C, Cauffiez C, Hamdane M, Sergeant N, Van Seuningen I, Leroy X, Aubert S, and Perrais M
- Subjects
- Animals, Cell Line, Tumor, Cell Nucleus metabolism, Disease Progression, Heterografts, Humans, Kidney Neoplasms genetics, Kidney Neoplasms pathology, Mice, Mice, SCID, Mucin-1 genetics, Protein Subunits, Signal Transduction, Transfection, Amyloid Precursor Protein Secretases metabolism, Kidney Neoplasms metabolism, Mucin-1 metabolism
- Abstract
MUC1 is a membrane-anchored mucin and its cytoplasmic tail (CT) can interact with many signaling pathways and act as a co-transcription factor to activate genes involved in tumor progression and metastasis. MUC1 is overexpressed in renal cell carcinoma with correlation to prognosis and has been implicated in the hypoxic pathway, the main renal carcinogenetic pathway. In this context, we assessed the effects of MUC1 overexpression on renal cancer cells properties. Using shRNA strategy and/or different MUC1 constructs, we found that MUC1-extracellular domain and MUC1-CT are involved in increase of migration, cell viability, resistance to anoikis and in decrease of cell aggregation in cancer cells. Invasiveness depends only on MUC1-CT. Then, by using siRNA strategy and/or pharmacological inhibitors or peptides, we showed that sheddases ADAM10, ADAM17 and gamma-secretase are necessary for MUC1 C-terminal subunit (MUC1-C) nuclear location and in increase of invasion property. Finally, MUC1 overexpression increases ADAM10/17 protein expression suggesting a positive regulatory loop. In conclusion, we report that MUC1 acts in renal cancer progression and MUC1-C nuclear localization drives invasiveness of cancer cells through a sheddase/gamma secretase dependent pathway. MUC1 appears as a therapeutic target by blocking MUC1 cleavage or nuclear translocation by using pharmacological approach and peptide strategies.
- Published
- 2014
- Full Text
- View/download PDF
28. Sources of pre-analytical variations in yield of DNA extracted from blood samples: analysis of 50,000 DNA samples in EPIC.
- Author
-
Caboux E, Lallemand C, Ferro G, Hémon B, Mendy M, Biessy C, Sims M, Wareham N, Britten A, Boland A, Hutchinson A, Siddiq A, Vineis P, Riboli E, Romieu I, Rinaldi S, Gunter MJ, Peeters PH, van der Schouw YT, Travis R, Bueno-de-Mesquita HB, Canzian F, Sánchez MJ, Skeie G, Olsen KS, Lund E, Bilbao R, Sala N, Barricarte A, Palli D, Navarro C, Panico S, Redondo ML, Polidoro S, Dossus L, Boutron-Ruault MC, Clavel-Chapelon F, Trichopoulou A, Trichopoulos D, Lagiou P, Boeing H, Fisher E, Tumino R, Agnoli C, and Hainaut P
- Subjects
- Adult, Age Factors, Aged, Body Mass Index, Case-Control Studies, DNA blood, Erythrocytes chemistry, Female, Genotyping Techniques, Hemolysis, Humans, Male, Middle Aged, Observer Variation, Prospective Studies, Reproducibility of Results, Sex Factors, Smoking, DNA isolation & purification, Leukocytes, Mononuclear chemistry, Specimen Handling standards
- Abstract
The European Prospective Investigation into Cancer and nutrition (EPIC) is a long-term, multi-centric prospective study in Europe investigating the relationships between cancer and nutrition. This study has served as a basis for a number of Genome-Wide Association Studies (GWAS) and other types of genetic analyses. Over a period of 5 years, 52,256 EPIC DNA samples have been extracted using an automated DNA extraction platform. Here we have evaluated the pre-analytical factors affecting DNA yield, including anthropometric, epidemiological and technical factors such as center of subject recruitment, age, gender, body-mass index, disease case or control status, tobacco consumption, number of aliquots of buffy coat used for DNA extraction, extraction machine or procedure, DNA quantification method, degree of haemolysis and variations in the timing of sample processing. We show that the largest significant variations in DNA yield were observed with degree of haemolysis and with center of subject recruitment. Age, gender, body-mass index, cancer case or control status and tobacco consumption also significantly impacted DNA yield. Feedback from laboratories which have analyzed DNA with different SNP genotyping technologies demonstrate that the vast majority of samples (approximately 88%) performed adequately in different types of assays. To our knowledge this study is the largest to date to evaluate the sources of pre-analytical variations in DNA extracted from peripheral leucocytes. The results provide a strong evidence-based rationale for standardized recommendations on blood collection and processing protocols for large-scale genetic studies.
- Published
- 2012
- Full Text
- View/download PDF
29. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition.
- Author
-
Bakken K, Fournier A, Lund E, Waaseth M, Dumeaux V, Clavel-Chapelon F, Fabre A, Hémon B, Rinaldi S, Chajes V, Slimani N, Allen NE, Reeves GK, Bingham S, Khaw KT, Olsen A, Tjønneland A, Rodriguez L, Sánchez MJ, Etxezarreta PA, Ardanaz E, Tormo MJ, Peeters PH, van Gils CH, Steffen A, Schulz M, Chang-Claude J, Kaaks R, Tumino R, Gallo V, Norat T, Riboli E, Panico S, Masala G, González CA, and Berrino F
- Subjects
- Aged, Breast Neoplasms etiology, Denmark epidemiology, Estrogen Replacement Therapy adverse effects, Europe epidemiology, Follow-Up Studies, France epidemiology, Germany epidemiology, Greece epidemiology, Humans, Italy epidemiology, Middle Aged, Netherlands epidemiology, Norway epidemiology, Postmenopause, Proportional Hazards Models, Prospective Studies, Risk Factors, Spain epidemiology, Sweden epidemiology, United Kingdom epidemiology, Breast Neoplasms epidemiology, Estrogen Replacement Therapy methods, Registries statistics & numerical data, Surveys and Questionnaires
- Abstract
Menopausal hormone therapy (MHT) is characterized by use of different constituents, regimens and routes of administration. We investigated the association between the use of different types of MHT and breast cancer risk in the EPIC cohort study. The analysis is based on data from 133,744 postmenopausal women. Approximately 133,744 postmenopausal women contributed to this analysis. Information on MHT was derived from country-specific self-administered questionnaires with a single baseline assessment. Incident breast cancers were identified through population cancer registries or by active follow-up (mean: 8.6 yr). Overall relative risks (RR) and 95% confidence interval (CI) were derived from country-specific Cox proportional hazard models estimates. A total of 4312 primary breast cancers were diagnosed during 1,153,747 person-years of follow-up. Compared with MHT never users, breast cancer risk was higher among current users of estrogen only (RR: 1.42, 95% CI 1.23-1.64) and higher still among current users of combined MHT (RR: 1.77, 95% CI 1.40-2.24; p = 0.02 for combined vs. estrogen-only). Continuous combined regimens conferred a 43% (95% CI: 19-72%) greater risk compared with sequential regimens. There was no significant difference between progesterone and testosterone derivatives in sequential regimens. There was no significant variation in risk linked to the estrogenic component of MHT, neither for oral vs. cutaneous administration nor for estradiol compounds vs. conjugated equine estrogens. Estrogen-only and combined MHT uses were associated with increased breast cancer risk. Continuous combined preparations were associated with the highest risk. Further studies are needed to disentangle the effects of the regimen and the progestin component., (Copyright © 2010 UICC.)
- Published
- 2011
- Full Text
- View/download PDF
30. MUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression.
- Author
-
Aubert S, Fauquette V, Hémon B, Lepoivre R, Briez N, Bernard D, Van Seuningen I, Leroy X, and Perrais M
- Subjects
- Animals, Blotting, Western, Carcinoma, Renal Cell genetics, Carcinoma, Renal Cell metabolism, Cell Hypoxia, Cell Line, Cell Line, Tumor, Cell Movement, Chromatin Immunoprecipitation, Disease Progression, Humans, Immunohistochemistry, Ischemia genetics, Ischemia metabolism, Ischemia pathology, Kidney blood supply, Kidney Neoplasms genetics, Kidney Neoplasms metabolism, Mucin-1 genetics, Neoplasm Staging, Promoter Regions, Genetic genetics, Protein Binding, RNA Interference, Rats, Response Elements genetics, Reverse Transcriptase Polymerase Chain Reaction, Tissue Array Analysis, Carcinoma, Renal Cell pathology, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Kidney Neoplasms pathology, Mucin-1 metabolism
- Abstract
The hypoxia inducible factor (HIF) signaling pathway is known as the main renal carcinogenetic pathway. MUC1, an O-glycoprotein membrane-bound mucin, is overexpressed in clear renal cell carcinomas (cRCC) with correlation to two major prognostic factors: tumor-node-metastasis stage and nuclear Fürhman grade. We questioned whether there is a direct link between the HIF pathway and MUC1 overexpression in renal tumors. Interestingly, we observed concomitant increase of HIF-1alpha and MUC1 in metastatic cRCC group versus nonmetastatic cRCC group. Using different renal cell models and small interfering RNA assays targeting either HIF-1alpha or YC-1, a HIF-1 pharmacologic inhibitor, we showed induction of MUC1 expression under hypoxia by a HIF-dependent mechanism. Chromatin immunoprecipitation assay showed a direct binding of HIF-1alpha at the MUC1 promoter. In addition, combined site-directed mutagenesis and gel shift assay allowed the identification of two functional putative hypoxia responsive elements at -1488/-1485 and at -1510/-1507 in the promoter. Using a rat kidney model of ischemia/reperfusion, we confirmed in vivo that clamping renal pedicle for 1 hour followed by 2 hours of reperfusion induced increased MUC1 expression. Furthermore, MUC1 knockdown induced significant reduction of invasive and migration properties of renal cancer cells under hypoxia. Altogether, these results show that MUC1 is directly regulated by HIF-1alpha and affects the invasive and migration properties of renal cancer cells. Thus, MUC1 could serve as a potential therapeutic target in cRCC.
- Published
- 2009
- Full Text
- View/download PDF
31. Activation of MUC1 mucin expression by bile acids in human esophageal adenocarcinomatous cells and tissues is mediated by the phosphatidylinositol 3-kinase.
- Author
-
Mariette C, Piessen G, Leteurtre E, Hémon B, Triboulet JP, and Van Seuningen I
- Subjects
- Adenocarcinoma pathology, Cell Line, Tumor, Deoxycholic Acid pharmacology, Esophageal Neoplasms pathology, Esophagus metabolism, Humans, Immunohistochemistry, In Vitro Techniques, Mucin 5AC, Mucin-1 genetics, Mucins metabolism, Mucous Membrane metabolism, Promoter Regions, Genetic drug effects, RNA, Messenger metabolism, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, Taurocholic Acid pharmacology, Transfection, Up-Regulation, Adenocarcinoma metabolism, Bile Acids and Salts pharmacology, Esophageal Neoplasms metabolism, Mucin-1 metabolism, Phosphatidylinositol 3-Kinases metabolism
- Abstract
Background: In esophageal adenocarcinoma, MUC1 mucin expression increases in early stages of the carcinogenetic sequence, during which bile reflux has been identified as a major carcinogen. However, no link between MUC1 overexpression and the presence of bile acids in the reflux has been established so far, and molecular mechanisms regulating MUC1 expression during esophageal carcinogenetic sequence are unknown. Our aim was to identify (1) the bile acids able to upregulate MUC1 expression in esophageal cancer cells and mucosal samples, (2) the regulatory regions in MUC1 promoter responsive to bile acids, and (3) the signaling pathway(s) involved in this regulation., Methods: MUC1 mRNA and mucin expression were studied by the means of real-time reverse transcriptase polymerase chain reaction (RT-PCR) and immunohistochemistry, both in the human esophageal OE33 adenocarcinoma cell line and in an ex vivo explant model. MUC1 promoter was cloned and transcription regulation was studied by transient cell transfection to identify the bile acid-responsive regions. Signaling pathways involved were identified using specific pharmacologic inhibitors and siRNA approach., Results: Taurocholic, taurodeoxycholic, taurochenodeoxycholic, glycocholic, sodium glycocholate, and deoxycholic bile acids upregulated MUC1 mRNA and protein expression. The highest induction was obtained with deoxycholic and taurocholic acids in both cellular and explant models. The bile acid-mediated upregulation of MUC1 transcription occurs at the promoter level, with responsive elements located in the -1472/-234 region of the promoter, and involves the phosphatidylinositol 3-kinase signaling pathway., Conclusions: Bile acids induce MUC1 mucin overexpression in human esophageal adenocarcinoma cells and tissues by activating its transcription through a process involving phosphatidylinositol 3-kinase.
- Published
- 2008
- Full Text
- View/download PDF
32. Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha.
- Author
-
Piessen G, Jonckheere N, Vincent A, Hémon B, Ducourouble MP, Copin MC, Mariette C, and Van Seuningen I
- Subjects
- Bile Reflux metabolism, Cell Line, Tumor, Esophageal Neoplasms metabolism, Hepatocyte Nuclear Factor 4 genetics, Hepatocyte Nuclear Factor 4 metabolism, Humans, Immunohistochemistry, Mucin-4, Mucins metabolism, Promoter Regions, Genetic, RNA, Small Interfering metabolism, Transcription, Genetic, Transfection, Up-Regulation, Esophageal Neoplasms genetics, Gene Expression Regulation, Neoplastic, Hepatocyte Nuclear Factor 1-alpha metabolism, Mucins genetics, Taurochenodeoxycholic Acid pharmacology, Taurodeoxycholic Acid pharmacology
- Abstract
MUC4 (mucin 4) is a membrane-bound mucin overexpressed in the early steps of oesophageal carcinogenesis and implicated in tumour progression. We previously showed that bile acids, main components of gastro-oesophageal reflux and tumour promoters, up-regulate MUC4 expression [Mariette, Perrais, Leteurtre, Jonckheere, Hemon, Pigny, Batra, Aubert, Triboulet and Van Seuningen (2004) Biochem. J. 377, 701-708]. HNF (hepatocyte nuclear factor) 1alpha and HNF4alpha transcription factors are known to mediate bile acid effects, and we previously identified cis-elements for these factors in MUC4 distal promoter. Our aim was to demonstrate that these two transcription factors were directly involved in MUC4 activation by bile acids. MUC4, HNF1alpha and HNF4alpha expressions were evaluated by immunohistochemistry in human oesophageal tissues. Our results indicate that MUC4, HNF1alpha and HNF4alpha were co-expressed in oesophageal metaplastic and adenocarcinomatous tissues. Studies at the mRNA, promoter and protein levels indicated that HNF1alpha regulates endogenous MUC4 expression by binding to two cognate cis-elements respectively located at -3332/-3327 and -3040/-3028 in the distal promoter. We also showed by siRNA (small interfering RNA) approach, co-transfection and site-directed mutagenesis that HNF1alpha mediates taurodeoxycholic and taurochenodeoxycholic bile acid activation of endogenous MUC4 expression and transcription in a dose-dependent manner. In conclusion, these results describe a new mechanism of regulation of MUC4 expression by bile acids, in which HNF1alpha is a key mediator. These results bring new insights into MUC4 up-regulation in oesophageal carcinoma associated with bile reflux.
- Published
- 2007
- Full Text
- View/download PDF
33. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition.
- Author
-
Norat T, Bingham S, Ferrari P, Slimani N, Jenab M, Mazuir M, Overvad K, Olsen A, Tjønneland A, Clavel F, Boutron-Ruault MC, Kesse E, Boeing H, Bergmann MM, Nieters A, Linseisen J, Trichopoulou A, Trichopoulos D, Tountas Y, Berrino F, Palli D, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HB, Peeters PH, Engeset D, Lund E, Skeie G, Ardanaz E, González C, Navarro C, Quirós JR, Sanchez MJ, Berglund G, Mattisson I, Hallmans G, Palmqvist R, Day NE, Khaw KT, Key TJ, San Joaquin M, Hémon B, Saracci R, Kaaks R, and Riboli E
- Subjects
- Adult, Aged, Animals, Europe epidemiology, Female, Humans, Life Style, Male, Middle Aged, Multivariate Analysis, Odds Ratio, Poultry, Proportional Hazards Models, Prospective Studies, Risk Assessment, Risk Factors, Surveys and Questionnaires, Colorectal Neoplasms epidemiology, Colorectal Neoplasms etiology, Dietary Fiber administration & dosage, Feeding Behavior, Fishes, Meat
- Abstract
Background: Current evidence suggests that high red meat intake is associated with increased colorectal cancer risk. High fish intake may be associated with a decreased risk, but the existing evidence is less convincing., Methods: We prospectively followed 478 040 men and women from 10 European countries who were free of cancer at enrollment between 1992 and 1998. Information on diet and lifestyle was collected at baseline. After a mean follow-up of 4.8 years, 1329 incident colorectal cancers were documented. We examined the relationship between intakes of red and processed meat, poultry, and fish and colorectal cancer risk using a proportional hazards model adjusted for age, sex, energy (nonfat and fat sources), height, weight, work-related physical activity, smoking status, dietary fiber and folate, and alcohol consumption, stratified by center. A calibration substudy based on 36 994 subjects was used to correct hazard ratios (HRs) and 95% confidence intervals (CIs) for diet measurement errors. All statistical tests were two-sided., Results: Colorectal cancer risk was positively associated with intake of red and processed meat (highest [>160 g/day] versus lowest [<20 g/day] intake, HR = 1.35, 95% CI = 0.96 to 1.88; Ptrend = .03) and inversely associated with intake of fish (>80 g/day versus <10 g/day, HR = 0.69, 95 % CI = 0.54 to 0.88; Ptrend<.001), but was not related to poultry intake. Correcting for measurement error strengthened the associations between colorectal cancer and red and processed meat intake (per 100-g increase HR = 1.25, 95% CI =1.09 to 1.41, Ptrend = .001 and HR = 1.55, 95% CI = 1.19 to 2.02, Ptrend = .001 before and after calibration, respectively) and for fish (per 100 g increase HR = 0.70, 95% CI = 0.57 to 0.87, Ptrend<.001 and HR = 0.46, 95% CI = 0.27 to 0.77, Ptrend = .003; before and after correction, respectively). In this study population, the absolute risk of development of colorectal cancer within 10 years for a study subject aged 50 years was 1.71% for the highest category of red and processed meat intake and 1.28% for the lowest category of intake and was 1.86% for subjects in the lowest category of fish intake and 1.28% for subjects in the highest category of fish intake., Conclusions: Our data confirm that colorectal cancer risk is positively associated with high consumption of red and processed meat and support an inverse association with fish intake.
- Published
- 2005
- Full Text
- View/download PDF
34. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).
- Author
-
Bezemer ID, Rinaldi S, Dossus L, Gils CH, Peeters PH, Noord PA, Bueno-de-Mesquita HB, Johnsen SP, Overvad K, Olsen A, Tjønneland A, Boeing H, Lahmann PH, Linseisen J, Nagel G, Allen N, Roddam A, Bingham S, Khaw KT, Kesse E, Téhard B, Clavel-Chapelon F, Agudo A, Ardanaz E, Quiros JR, Amiano P, Martínez-Garcia C, Tormo MJ, Pala V, Panico S, Vineis P, Palli D, Tumino R, Trichopoulou A, Baibas N, Zilis D, Hémon B, Norat T, Riboli E, and Kaaks R
- Subjects
- Androgens blood, Cross-Sectional Studies, Estrogens blood, Female, Humans, Insulin-Like Growth Factor Binding Protein 3 blood, Middle Aged, Postmenopause, Premenopause, Prospective Studies, Sex Hormone-Binding Globulin analysis, Body Mass Index, C-Peptide blood, Insulin-Like Growth Factor I analysis, Waist-Hip Ratio
- Abstract
Objectives: The risk of some cancers is positively associated with body weight, which may influence circulating levels of sex-steroid hormones, insulin and IGF-I. Interrelationships between these hormones and the associations with adiposity were evaluated in healthy women participating in the European Prospective Investigation into Cancer and Nutrition (EPIC)., Methods: A cross-sectional analysis was performed on anthropometric and hormonal data from 743 pre- and 1217 postmenopausal women. Body mass index (BMI) and waist circumference were used as indicators of adiposity. C-peptide, Insulin Growth Factor (IGF)-I, Insulin Growth Factor binding protein (IGFBP)-3, androgens, estrogens and sex hormone binding globulin (SHBG) were measured by immunoassays; free sex steroid concentrations were calculated., Results: BMI and waist circumference were positively correlated with estrogens in postmenopausal women and with C-peptide, free testosterone and inversely with SHBG in all women. C-peptide and IGF-I were inversely correlated with SHBG, and positively with free sex steroids in postmenopausal women. IGF-I was positively associated with postmenopausal estrogens and androgen concentrations in all women., Conclusions: Sex-steroid concentrations appear to be regulated along several axes. Adiposity correlated directly with estrogens in postmenopausal women and with insulin, resulting in lower SHBG and increased levels of free sex steroids. Independent of adiposity and insulin, IGF-I was associated with decreased SHBG levels, and increased concentrations of androgens and postmenopausal estrogens.
- Published
- 2005
- Full Text
- View/download PDF
35. Transcriptional regulation of human mucin MUC4 by bile acids in oesophageal cancer cells is promoter-dependent and involves activation of the phosphatidylinositol 3-kinase signalling pathway.
- Author
-
Mariette C, Perrais M, Leteurtre E, Jonckheere N, Hémon B, Pigny P, Batra S, Aubert JP, Triboulet JP, and Van Seuningen I
- Subjects
- Adenocarcinoma enzymology, Adenocarcinoma metabolism, Adenocarcinoma pathology, Bile Acids and Salts pharmacology, Biomarkers, Tumor biosynthesis, Biomarkers, Tumor genetics, Cell Line, Tumor, Enzyme Activation physiology, Esophageal Neoplasms enzymology, Esophageal Neoplasms metabolism, Esophageal Neoplasms pathology, Gastric Mucins genetics, Gene Expression Regulation drug effects, Gene Expression Regulation physiology, Humans, Mucin-1 biosynthesis, Mucin-4, Mucins biosynthesis, Mucous Membrane chemistry, Mucous Membrane metabolism, Peptide Fragments biosynthesis, Promoter Regions, Genetic drug effects, Promoter Regions, Genetic genetics, RNA, Messenger biosynthesis, RNA, Messenger metabolism, Signal Transduction drug effects, Stomach Neoplasms enzymology, Stomach Neoplasms metabolism, Stomach Neoplasms pathology, Transcription, Genetic drug effects, Up-Regulation drug effects, Up-Regulation physiology, Adenocarcinoma genetics, Bile Acids and Salts physiology, Esophageal Neoplasms genetics, Mucins genetics, Phosphatidylinositol 3-Kinases metabolism, Promoter Regions, Genetic physiology, Signal Transduction physiology, Stomach Neoplasms genetics, Transcription, Genetic physiology
- Abstract
Abnormal gastro-oesophageal reflux and bile acids have been linked to the presence of Barrett's oesophageal premalignant lesion associated with an increase in mucin-producing goblet cells and MUC4 mucin gene overexpression. However, the molecular mechanisms underlying the regulation of MUC4 by bile acids are unknown. Since total bile is a complex mixture, we undertook to identify which bile acids are responsible for MUC4 up-regulation by using a wide panel of bile acids and their conjugates. MUC4 apomucin expression was studied by immunohistochemistry both in patient biopsies and OE33 oesophageal cancer cell line. MUC4 mRNA levels and promoter regulation were studied by reverse transcriptase-PCR and transient transfection assays respectively. We show that among the bile acids tested, taurocholic, taurodeoxycholic, taurochenodeoxycholic and glycocholic acids and sodium glycocholate are strong activators of MUC4 expression and that this regulation occurs at the transcriptional level. By using specific pharmacological inhibitors of mitogen-activated protein kinase, phosphatidylinositol 3-kinase, protein kinase A and protein kinase C, we demonstrate that bile acid-mediated up-regulation of MUC4 is promoter-specific and mainly involves activation of phosphatidylinositol 3-kinase. This new mechanism of regulation of MUC4 mucin gene points out an important role for bile acids as key molecules in targeting MUC4 overexpression in early stages of oesophageal carcinogenesis.
- Published
- 2004
- Full Text
- View/download PDF
36. Induction of a storage phenotype and abnormal intracellular localization of apical glycoproteins are two independent responses to GalNAcalpha-O-bn.
- Author
-
Leteurtre E, Gouyer V, Delacour D, Hémon B, Pons A, Richet C, Zanetta JP, and Huet G
- Subjects
- Antigens metabolism, Antigens, Neoplasm, Carcinoembryonic Antigen metabolism, Cell Line, Cell Polarity, Endosomes metabolism, Galactose analogs & derivatives, Glycosylation, Humans, Immunohistochemistry, Kinetics, Lysosomes metabolism, Microscopy, Confocal, Microscopy, Electron, Microscopy, Fluorescence, Mucin-1, Mucins, Galactose metabolism, Glycoproteins metabolism
- Abstract
Our previous studies on an inhibitor of O-glycosylation of glycoproteins, GalNAcalpha-O-bn, in the model of enterocytic HT-29 cells, have shown at the cellular level an alteration of the normal localization of apical glycoproteins, and at the biochemical level an in situ synthesis and storage of sialylated GalNAcalpha-O-bn oligosaccharides. The purpose of this study was to examine if a relation existed between these two events, using different cell lines. Intracellular storage of GalNAcalpha-O-bn metabolites occurred in HT-29 and CAPAN-1 cells but not in Caco-2 cells. On the other hand, an accumulation of endosomal/lysosomal compartments was observed in HT-29 and CAPAN-1 cells but not in Caco-2 cells. These data focused on a GalNAcalpha-O-bn-derived storage phenotype in HT-29 and CAPAN-1 cells. The apical membrane glycoproteins MUC1 and CEA showed an abnormal localization inside intracytoplasmic vesicles in HT-29 cells, whereas they kept their normal localization in Caco-2 and CAPAN-1 cells. Studies on the glycosylation of these apical glycoproteins showed that GalNAcalpha-O-bn inhibited the glycosylation in a cell-specific manner. The alteration in the apical targeting of glycoproteins, and the appearance of a GalNAcalpha-O-bn-derived storage phenotype are two independent and cell type-specific events. The former depends on the inhibition pattern of the glycosylation of endogenous glycoproteins, whereas the latter is connected to the intracellular accumulation of GalNAcalpha-O-bn metabolites.
- Published
- 2003
- Full Text
- View/download PDF
37. Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion.
- Author
-
Hennebicq-Reig S, Lesuffleur T, Capon C, De Bolos C, Kim I, Moreau O, Richet C, Hémon B, Recchi MA, Maës E, Aubert JP, Real FX, Zweibaum A, Delannoy P, Degand P, and Huet G
- Subjects
- Acetylgalactosamine pharmacology, Adenocarcinoma, Carbohydrate Sequence, Colonic Neoplasms, Galactose metabolism, Glycosylation, Glycosyltransferases metabolism, Humans, Kinetics, Microsomes enzymology, Molecular Sequence Data, Mucin 5AC, Mucins chemistry, Nuclear Magnetic Resonance, Biomolecular, Oligosaccharides chemistry, Oligosaccharides metabolism, Polymerase Chain Reaction, Sialic Acids metabolism, Tumor Cells, Cultured, Acetylgalactosamine analogs & derivatives, Benzyl Compounds pharmacology, Mucins biosynthesis, Mucins metabolism, Oligosaccharides biosynthesis
- Abstract
Previous work has shown that treatment of HT-29 methotrexate (MTX) cells with benzyl-N-acetyl-alpha-D-galactosaminide results in profound changes in mucin oligosaccharide chains. To analyse in depth the effect of this drug, we first determined the structure of mucin oligosaccharide chains synthesized by HT-29 MTX cells and the changes induced by permanent drug exposure. Mucins from untreated cells contained nine monosialylated structures (core types 1, 2, 3 and 4) and four disialylated structures (types 1, 2 and 4). Core 1 structures predominated, in particular NeuAcalpha2-3Galbeta1-3GalNAc-ol. Exposure of HT-29 MTX cells to benzyl-N-acetyl-alpha-D-galactosaminide from days 2-21 resulted in a decrease in intracellular mucins and both their sialic acid and galactose content, and an increased T (Galbeta1-3GalNAcalpha-O-Ser/Thr) and Tn (GalNAcalpha-O-Ser/Thr) antigenicity. A 3-fold increase in both Galbeta1-3GalNAc alpha2, 3-sialyltransferase activity and mRNA expression was detected. At the ultrastructural level, T-antigen was not detectable in mucin droplets in control cells, but was strongly expressed in intracytoplasmic vesicles in treated cells. In these cells, MUC1 and MUC3 transcripts were up-regulated, whereas MUC2, MUC5B and MUC5AC were down-regulated. Furthermore, constitutive and secretagogue-induced MUC5AC secretion was reduced and no mucus layer was detected. In conclusion, benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation and altered regulation of MUC5AC secretion.
- Published
- 1998
- Full Text
- View/download PDF
38. Regulation of cathepsin D dependent on the phenotype of colon carcinoma cells.
- Author
-
Hennebicq Reig S, Kim I, Janin A, Grard G, Hémon B, Moreau O, Porchet N, Aubert JP, Degand P, and Huet G
- Subjects
- Cathepsin D genetics, Colonic Neoplasms pathology, HT29 Cells, Humans, Microscopy, Immunoelectron, Phenotype, RNA, Messenger analysis, Cathepsin D metabolism, Colonic Neoplasms enzymology
- Abstract
We have studied the intracellular trafficking of cathepsin D in different colon carcinoma cell populations: the HT-29 cell line, composed of >95% undifferentiated cells; 2 subpopulations derived from this cell line, containing cells committed to differentiation into mucin-secreting cells (HT-29 MTX) or enterocyte-like cells (HT-29 G-) after confluence; and the Caco-2 cell line, which spontaneously differentiates into enterocyte-like cells after confluence. Post-confluent undifferentiated HT-29 cells and differentiated enterocyte-like HT-29 G- and Caco-2 cells secrete significant levels of cathepsin D in culture medium, in contrast to post-confluent differentiated mucin-secreting HT-29 MTX cells, which secrete this enzyme at a very low level. The intracellular content and the mRNA level of cathepsin D increase after confluence in the different cell types, particularly in Caco-2 cells, which intensify the secretion of cathepsin D along with the differentiation process post-confluence. Membrane-associated mature cathepsin D was detected in HT-29 cells but not in Caco-2 cells. In the different types of cell, pro-cathepsin D associates with the membrane concomitantly to its binding to an Mr 72,000 protein. Membrane association persists after dissociation of the complex in HT-29 cells but not in Caco-2 cells. In the mucin-secreting HT-29 MTX cells, cathepsin D was immunolocalised to the membrane of mucin vacuoles localised under the brush border. Our results show that cathepsin D can be regulated differently in colon carcinoma cells, and this finding might have specific functional implications for each cell type.
- Published
- 1996
- Full Text
- View/download PDF
39. Nitrosamine, nitrate and nitrite in relation to gastric cancer: a case-control study in Marseille, France.
- Author
-
Pobel D, Riboli E, Cornée J, Hémon B, and Guyader M
- Subjects
- Adenocarcinoma etiology, Aged, Case-Control Studies, Diet, Energy Intake, Female, France epidemiology, Humans, Male, Odds Ratio, Risk Factors, Stomach Neoplasms etiology, Surveys and Questionnaires, Adenocarcinoma epidemiology, Dimethylnitrosamine adverse effects, Nitrates adverse effects, Nitrites adverse effects, Stomach Neoplasms epidemiology
- Abstract
A case-control study on gastric cancer and diet was conducted in Marseille (France). Ninety-two patients with histologically confirmed adenocarcinoma and 128 controls undergoing functional reeducation for injuries or trauma were interviewed by a trained dietician using a dietary history questionnaire on their usual diet during the year preceding the first symptoms for cases, or preceding interview for controls. Intake of nitrite, nitrate and pre-formed N-nitrosodimethylamine (NDMA) from food was estimated using a food composition table compiled ad hoc. Odds ratios (ORs) were calculated after adjustment for age, sex, occupation and calorie intake. The results indicated that high intake of NDMA was associated with increased risk for gastric cancer. The ORs for the second and third tertile of NDMA intake were: OR2 = 4.13 (95% CI = 0.93 18.27) and OR3 = 7.00 (95% CI = 1.85 to 26.46). Intake of nitrate and nitrite was not associated with increased risk of stomach cancer. Consumption of vegetables was protective in general and independent of their estimated nitrate content.
- Published
- 1995
- Full Text
- View/download PDF
40. A case-control study of gastric cancer and nutritional factors in Marseille, France.
- Author
-
Cornée J, Pobel D, Riboli E, Guyader M, and Hémon B
- Subjects
- Adult, Aged, Case-Control Studies, Energy Intake, Female, France epidemiology, Humans, Male, Middle Aged, Odds Ratio, Risk Factors, Surveys and Questionnaires, Adenocarcinoma epidemiology, Diet, Nutritional Physiological Phenomena, Stomach Neoplasms epidemiology
- Abstract
A case-control study was conducted in Marseille (France) to investigate the relationship between usual diet and risk of gastric cancer. Patients with histologically confirmed gastric adenocarcinoma were identified in 8 major centres for gastric surgery. Controls were selected in specialized medical centres from patients undergoing functional reeducation for injuries or trauma, according to the age and sex distributions of the cases. The study involved 92 cases and 128 controls who were interviewed with a dietary history questionnaire on their usual diet during the year preceding first symptoms for cases, or preceding interview for controls. Odds ratios for specific foods were calculated after adjustment for age, sex, occupation and energy intake. A reduced risk was observed for consumption of raw vegetables (OR2: 0.55; OR3: 0.41 for the second and third tertiles, respectively), fresh fruit (OR2: 0.63; OR3: 0.50), vegetable oil (OR2: 0.60; OR3: 0.52), pasta and rice (OR2: 1.06; OR3: 0.50) whereas consumption of cakes and pastries (OR2: 1.02; OR3: 2.96), sugar and confectionery (OR2: 0.96; OR3: 1.68) was associated with an increased risk. An increased risk was found for intake of saturated fat (OR2: 1.49; OR3: 1.67), simple sugars (OR2: 1.18; OR3: 1.78) and calcium (OR2: 1.84; OR3: 2.57). A decreased risk was observed with intake of fiber (OR2: 0.49; OR3: 0.59), fibre from vegetables and fruit (OR2: 0.83; OR3: 0.53) and iron (OR2: 0.70; OR3: 0.41).
- Published
- 1995
- Full Text
- View/download PDF
41. Diet and bladder cancer in Spain: a multi-centre case-control study.
- Author
-
Riboli E, González CA, López-Abente G, Errezola M, Izarzugaza I, Escolar A, Nebot M, Hémon B, and Agudo A
- Subjects
- Calcium adverse effects, Case-Control Studies, Dietary Fats adverse effects, Fruit, Humans, Male, Spain epidemiology, Urinary Bladder Neoplasms epidemiology, Vegetables, Diet adverse effects, Feeding Behavior, Urinary Bladder Neoplasms etiology
- Abstract
A multi-centre case-control study on bladder cancer and diet was carried out in 5 regions of Spain. We report results on 432 male cases and 792 matched controls. Usual dietary habits were investigated by means of an interview-based dietary history questionnaire. Bladder-cancer cases were selected from the registers of 12 hospitals located in the study areas. Each case was matched by sex, age and area of residence to 2 controls, one identified in the same hospital and one drawn from population lists. Descriptive analyses indicated that the average dietary pattern was typical of Mediterranean populations: a high P/S ratio, high intake of fish, fruits and vegetables and moderate or low intake of meat and dairy products. Relative risks for specific foods and nutrients were adjusted for tobacco smoking and energy intake. Subjects in the highest quarter of intake of saturated fat had a significantly increased risk of bladder cancer (RR for highest quarter = 2.25; 95% CI = 1.42 to 3.55). Moderate increases in risk for high intake of mono-unsaturated fats and calcium, and a slight decrease for iron were also found, but these disappeared after adjustment for saturated fat. Intake of vitamin E was related to slightly reduced risk (RR for highest quarter = 0.72; 95% CI = 0.48 to 1.09) which was not modified by adjustment for fat. No association was found with intake of retinol or carotene. These results, along with those of previous studies, suggest that saturated fat intake may influence the occurrence of bladder cancer.
- Published
- 1991
- Full Text
- View/download PDF
42. [Alzheimer's disease: study of the distribution of tau proteins constituting helical filament pairs in human central nervous tissue].
- Author
-
Parent M, Delacourte A, Défossez A, Hémon B, Han KK, and Petit H
- Subjects
- Adult, Aged, Antibodies, Monoclonal, Humans, Immunosorbent Techniques, Molecular Weight, Protein Conformation, tau Proteins, Alzheimer Disease metabolism, Brain Chemistry, Microtubule-Associated Proteins analysis
- Abstract
Tau proteins are the major components of Paired Helical Filaments (PHF) of Alzheimer's disease. Using the immunoblot technique and an antiserum against PHF, we have studied the distribution of Tau proteins in the different areas of normal human brains and Alzheimer brains. Tau proteins were clearly present in cortical grey matter but were difficult to detect in the white matter. In Alzheimer brains, we observed two differences: first, there is an important background due to the partial dissociation of the lesions containing Tau aggregates. Second, the profile of Tau proteins is modified, due to abnormal phosphorylation. Thus, Tau proteins are found in large amounts in the grey matter of the cortical areas and are not exclusively distributed in the axonal domain. The normal cortical distribution of Tau in the human brain correlates well with the distribution of histological lesions that contain PHF (neurofibrillary tangles and neuritic plaques) in the Alzheimer cortex.
- Published
- 1988
43. Characterization of two pathological tau protein, variants in Alzheimer brain cortices.
- Author
-
Flament S, Delacourte A, Hémon B, and Défossez A
- Subjects
- Aged, Aged, 80 and over, Alkaline Phosphatase pharmacology, Alzheimer Disease pathology, Humans, Middle Aged, Phosphorylation, tau Proteins, Alzheimer Disease metabolism, Microtubule-Associated Proteins metabolism, Neurofibrils pathology
- Abstract
Tau proteins were detected in brain tissue homogenates from 10 patients with Alzheimer's disease versus 10 age-matched controls using the immunoblot technique and 2 polyclonal antibodies: anti-paired helical filaments (PHF) and anti-human native Tau proteins. In control brains, both antisera detected identically the normal set of Tau proteins, with molecular weight (MW) ranging from 45 to 62 kDa. Moreover, in association areas of neocortex from Alzheimer brains, the antisera detected 2 additional Tau variants of 64 and 69 kDa. Tau 64 and 69 were not found in regions of Alzheimer brains where the Alzheimer pathology was absent (caudate nucleus or cerebellum for example). The heavy MW of Tau 64 and 69 is due to their phosphorylation state as shown by the decrease of their MW after alkaline phosphatase treatment. Therefore, Tau 64 and Tau 69 are specific markers of the Alzheimer's disease neuronal degenerating process and their characterization demonstrates that an abnormal phosphorylation of Tau really occurs during the disease. Tau 64 and 69 were isolated with normal Tau proteins while the PHF were insoluble. Therefore, Tau proteins are likely to be abnormally phosphorylated prior to their incorporation in the PHF structure. Consequently, they might appear before the lesions and might be instrumental for the search of biochemical deregulations that precede the neurofibrillary degeneration.
- Published
- 1989
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.